BIOCONNSEBiocon Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 14 Jan, 2026 · 22:31 IST

Biocon QIP - Placement Document approved by Fund Raising Committee

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.6%Reaction day
₹378.90
prior close
₹380.20
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.0%-0.7% vs market
Pharmaceuticals peers, median of 156sector-0.8%+0.2% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
-0.1
15m
+0.4
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.6+0.0-0.7-0.8+0.2
Next day
-1.0-0.4-0.6-1.8+0.8
2d
-3.7-2.9-0.8-3.9+0.3
3d
-3.7-3.9+0.2-4.7+1.0
4d
-1.7-2.7+1.0-3.8+2.1
5d
-3.1-4.4+1.3-5.1+2.0
1w
-2.3-2.3-0.1-4.4+2.1
15d
-1.6+1.4-3.0-1.5-0.1
1m
+0.4+0.1+0.3-4.0+4.3
2m
-0.6-8.2+7.7-10.0+9.4
3m
-7.6-0.8-6.7-1.9-5.7
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon Limited's Fund Raising Committee approved the Placement Document on January 14, 2026 for its Qualified Institutions Placement (QIP) of equity shares with face value of Rs 5. This follows earlier intimations dated January 12 and January 14, 2026. The committee meeting ran from 10:12 PM to 10:20 PM. No pricing, discount, premium, or investor details are disclosed in this filing.

Likely market impact

Procedural update on Biocon's QIP process. Watch for pricing and allotment details in upcoming filings to gauge share price impact.